Applications of 1-Aminocyclopropanecarboxylic Acid in Industrial Manufacturing

As a direct manufacturer, we supply 1-aminocyclopropanecarboxylic acid (ACC) to key downstream sectors where its specific biochemical properties and chemical reactivity play a critical role in finished product formulation. Below we detail its industrial applications, compliance standards, component ratios, process integration, and resulting product types across core markets—each grounded entirely in real-world manufacturing practices.

1. Plant Growth Regulator Precursor in Agrochemical Industry

Major agrochemical manufacturers incorporate ACC as a functional precursor in the synthesis or formulation of ethephon and other ethylene-releasing agents. Through highly controlled chemical processes, ACC serves as a substrate that modulates ethylene biosynthesis, crucial for post-harvest ripening and crop stress management products. Its strict purity and handling requirements ensure consistent regulatory compliance and product stability throughout the value chain from formulators to agronomic input suppliers.

Industry compliance standards

• FAO/WHO: Guidelines on Food and Agriculture Plant Protection Products
• ISO 2317: Technical requirements for plant growth substances
• EU Regulation No 1107/2009: Plant Protection Product approval
• REACH: Registration, Evaluation, Authorisation and Restriction of Chemicals

Typical usage ratio

• Integrated at 0.05%–0.5% by weight in plant growth regulator intermediates; precise loading refined based on the required ethylene output and downstream formulation stability

Downstream process integration

• Dosed during the compounding of plant regulator mother liquors or included in microencapsulated granulation processes; precise timing is critical for maintaining precursor integrity prior to final reactant addition and packaging

Final product types

• Ethephon-based plant growth regulators
• Post-harvest ethylene generators
• Horticultural maturation/senescence promotors

2. Biotechnological Production of Ethylene in Plant Tissue Culture

Commercial micropropagation and seed company laboratories use ACC to stimulate ethylene formation under controlled in vitro conditions. This approach supports research and commercial scaling of tissue cultures for high-value crops, enabling precise hormonal manipulation to induce rooting, shoot elongation, or synchronized flowering. Consistency and regulatory clarity are mandatory for reproducibility and safe downstream plantlet production, particularly for export markets.

Industry compliance standards

• OECD Test Guideline 414: Toxicity studies in plant cell/tissue cultures
• International Seed Testing Association (ISTA) Protocols
• US EPA 40 CFR Part 180: Tolerances for plant growth regulators
• ISO/IEC 17025: Laboratory testing accreditation

Typical usage ratio

• Utilized at 1–10 mg/L in Murashige and Skoog (MS) or customized media; adjusted according to species and required ethylene concentration for morphogenesis or rooting triggers

Downstream process integration

• Added directly to tissue culture medium before autoclaving or sterile filtered for post-autoclaving adjustment; process sequencing assures biological activity prior to explant inoculation and incubation

Final product types

• In vitro hardened seedlings
• Mass-propagated elite plant lines
• Commercial plantlet trays for agriculture/horticulture supply

3. Biochemical Research Reagents

Academic and industrial laboratories specify ACC as a high-purity reagent for research on ethylene biosynthesis, enzyme activity, and signal transduction studies in plant biology or plant-pathogen interactions. Its use supports quantitative analytical workflows that enable biochemical pathway elucidation and high-throughput screening of growth regulator modes of action. Purity, analytical validation, and full traceability are key for scientific rigor and regulatory support in publication and product development pipelines.

Industry compliance standards

• ACS Reagent Grade Specifications
• ISO 9001:2015 Quality management for research-grade chemicals
• GLP (Good Laboratory Practice) Compliance
• Lab-specific safety regulations (OSHA, JIS K 8001 in Japan)

Typical usage ratio

• Research concentrations from 0.1 mM–5 mM in custom experimental buffers; titration protocols depend on intended application and detection method (e.g., GC, HPLC, ELISA)

Downstream process integration

• Weighing within analytical balances followed by direct dissolution into assay media; often delivered through filtered stock solutions or aliquoting to prevent contamination in multi-user laboratories

Final product types

• Ethylene response assay kits
• Enzyme activity quantification kits
• Validated reference standards for academic publishing

4. Pharmaceutical Intermediate for Novel Amino Acid Derivatives

Pharmaceutical synthesis units utilize ACC as a key chiral building block in the production of innovative cyclopropane-containing amino acid analogues and peptidomimetics. These downstream compounds form part of clinical candidate development, small-molecule drug discovery, or as reference standards for analytical method validation. Usage demands strict adherence to traceable GMP frameworks and compendial controls across the supply chain, from the initial chemical transformation to API (active pharmaceutical ingredient) isolation and characterization.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for APIs
• United States Pharmacopeia (USP)
• European Pharmacopoeia (EP)
• FDA 21 CFR Parts 210/211: Manufacturing practice regulations

Typical usage ratio

• Input loadings for synthetic conversion (peptide coupling or asymmetric transformation): 0.1–1.0 molar equivalents versus other reactants; selected based on chirality requirements and route selectivity

Downstream process integration

• Incorporated as a solid reagent at the condensation, cyclization, or amide bond formation stage during multi-step synthesis; precise mass balance and trace impurity control support downstream API quality

Final product types

• Cyclopropane-conjugated peptide therapeutics (development stage)
• Non-standard amino acid pharmaceutical intermediates
• Reference standards for clinical candidate identification